Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use
Statins are widely prescribed medications to prevent cardiovascular events. While self-limited statin myopathy is relatively common, statin-induced necrotizing autoimmune myopathy (SINAM) is extremely uncommon, with incidence of two cases per million per year. We present a case of SINAM after a deca...
Main Authors: | Priyadarshani Sharma, Bidhya Timilsina, Janak Adhikari, Prem Parajuli, Rashmi Dhital, Niranjan Tachamo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-11-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20009666.2019.1702272 |
Similar Items
-
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study
by: Elena Treppo, et al.
Published: (2020-10-01) -
Statin-Associated Autoimmune Myopathy: Current Perspectives
by: Tiniakou E
Published: (2020-05-01) -
Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
by: Emma Frasson, et al.
Published: (2021-05-01) -
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients
by: Alain Meyer, et al.
Published: (2020-01-01) -
Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure – narrative review of the literature – case report
by: Carvalho AAS, et al.
Published: (2018-05-01)